Search research articles
Contact Us
Filters
Showing results (381-390 of 467) with videos related to
Page
of 47
Sort By:
BMC Nephrology
|
February 11, 2025
Risk factors for relapse and aggravation in membranous nephropathy after COVID-19 infection
Yue Shu, Jing Huang, Yi-Miao Zhang, et al.
Frontiers in Pharmacology
|
December 9, 2022
Characterization of three naturally occurring lignans, sesamol, sesamolin, and sesamin, as potent inhibitors of human cytochrome P450 46A1: Implications for treating excitatory neurotoxicity
Jie Du, Xiaodong Chen, Yongshun Zhao, et al.
European Journal of Medicinal Chemistry
|
November 18, 2017
Identification of highly potent BTK and JAK3 dual inhibitors with improved activity for the treatment of B-cell lymphoma
Yang Ge, Changyuan Wang, Shijie Song, et al.
European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences
|
July 13, 2014
PEPT1- and OAT1/3-mediated drug-drug interactions between bestatin and cefixime in vivo and in vitro in rats, and in vitro in human
Li Wang, Changyuan Wang, Qi Liu, et al.
Nuclear Medicine Communications
|
November 18, 2025
Uptake pattern of dual-nuclide PET in intracranial lesions
Yutao Ren, Qiang Meng, Hao Wu, et al.
Cell Biochemistry and Biophysics
|
March 6, 2025
Correction: FOXM1, a super enhancer-associated gene, is related to poorer prognosis and gemcitabine resistance in pancreatic cancer
Jian Jiang, Tianci Shen, Dan Chen, et al.
Clinical Journal of the American Society of Nephrology : CJASN
|
June 25, 2016
Clinical Significance of IgM and C3 Glomerular Deposition in Primary Focal Segmental Glomerulosclerosis
Yi-Miao Zhang, Qiu-Hua Gu, Jing Huang, et al.
British Journal of Pharmacology
|
August 6, 2019
Catalpol alleviates adriamycin-induced nephropathy by activating the SIRT1 signalling pathway in vivo and in vitro
Jiangnan Zhang, Ran Bi, Qiang Meng, et al.
Toxicology and Applied Pharmacology
|
April 17, 2018
Yangonin protects against cholestasis and hepatotoxity via activation of farnesoid X receptor in vivo and in vitro
Xiaoguang Gao, Ting Fu, Changyuan Wang, et al.
Oncotarget
|
January 5, 2017
Targeting P-glycoprotein function, p53 and energy metabolism: Combination of metformin and 2-deoxyglucose reverses the multidrug resistance of MCF-7/Dox cells to doxorubicin
Chaojun Xue, Changyuan Wang, Yaoting Sun, et al.
Page
of 47
Search research articles
Search
Showing results (381-390 of 467) with videos related to
Sort By:
Page
of 47
BMC Nephrology
|
February 11, 2025
Risk factors for relapse and aggravation in membranous nephropathy after COVID-19 infection
Yue Shu, Jing Huang, Yi-Miao Zhang, et al.
Frontiers in Pharmacology
|
December 9, 2022
Characterization of three naturally occurring lignans, sesamol, sesamolin, and sesamin, as potent inhibitors of human cytochrome P450 46A1: Implications for treating excitatory neurotoxicity
Jie Du, Xiaodong Chen, Yongshun Zhao, et al.
European Journal of Medicinal Chemistry
|
November 18, 2017
Identification of highly potent BTK and JAK3 dual inhibitors with improved activity for the treatment of B-cell lymphoma
Yang Ge, Changyuan Wang, Shijie Song, et al.
European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences
|
July 13, 2014
PEPT1- and OAT1/3-mediated drug-drug interactions between bestatin and cefixime in vivo and in vitro in rats, and in vitro in human
Li Wang, Changyuan Wang, Qi Liu, et al.
Nuclear Medicine Communications
|
November 18, 2025
Uptake pattern of dual-nuclide PET in intracranial lesions
Yutao Ren, Qiang Meng, Hao Wu, et al.
Cell Biochemistry and Biophysics
|
March 6, 2025
Correction: FOXM1, a super enhancer-associated gene, is related to poorer prognosis and gemcitabine resistance in pancreatic cancer
Jian Jiang, Tianci Shen, Dan Chen, et al.
Clinical Journal of the American Society of Nephrology : CJASN
|
June 25, 2016
Clinical Significance of IgM and C3 Glomerular Deposition in Primary Focal Segmental Glomerulosclerosis
Yi-Miao Zhang, Qiu-Hua Gu, Jing Huang, et al.
British Journal of Pharmacology
|
August 6, 2019
Catalpol alleviates adriamycin-induced nephropathy by activating the SIRT1 signalling pathway in vivo and in vitro
Jiangnan Zhang, Ran Bi, Qiang Meng, et al.
Toxicology and Applied Pharmacology
|
April 17, 2018
Yangonin protects against cholestasis and hepatotoxity via activation of farnesoid X receptor in vivo and in vitro
Xiaoguang Gao, Ting Fu, Changyuan Wang, et al.
Oncotarget
|
January 5, 2017
Targeting P-glycoprotein function, p53 and energy metabolism: Combination of metformin and 2-deoxyglucose reverses the multidrug resistance of MCF-7/Dox cells to doxorubicin
Chaojun Xue, Changyuan Wang, Yaoting Sun, et al.
Page
of 47